National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06AB03	FULSAC	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	435,405 L.L
N06AB03	FLUTIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	362,837 L.L
N05AB02	FLUPHENAZINE HCl	G	Fluphenazine (HCl) - 5mg	5mg	Tablet, scored	624,567 L.L
S01BC04	FLUROPTIC	G	Flurbiprofen sodium - 0.03% w/v	0.03% w/v	Drops solution	223,078 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 125mcg/actuation	125mcg/actuation	Inhalation suspension	802,274 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 250mcg/actutaion	250mcg/actutaion	Inhalation suspension	1,484,946 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Inhalation suspension	671,921 L.L
N06AB08	FAVERIN	B	Fluvoxamine maleate - 100mg	100mg	Tablet, film-scored	1,291,433 L.L
B03AD03	FOLIFER	G	Folic acid - 1mg, Iron bivalent (as dried ferrous sulfate) - 90mg		Tablet, film coated	1,408,347 L.L
B03BB01	FOLICIL	G	Folic acid - 5mg	5mg	Tablet	584,571 L.L
R03AK07	FORACORT 400	G	Formoterol fumarate - 4.5mcg/inhalation, Budesonide - 400mcg/inhalation		Metered dose inhaler	3,104,276 L.L
R03AK07	FORACORT 200	G	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 200mcg/inhalation		Metered dose inhaler	2,159,555 L.L
J01XX01	FOSFOKEY	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L
J01XX01	FOSFOLAG	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	46,628,557 L.L
L02BA03	FULVESTRANT ARROW	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	12,644,009 L.L
L02BA03	FULVESTRANT EVER PHARMA	G	Fulvestrant - 250mg/5ml	250mg	Injectable solution	29,905,966 L.L
L02BA03	FUXRAN	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	39,382,304 L.L
L02BA03	FASLODEX	B	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	451,531 L.L
C03CA01	FRURETIC	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	2,600,655 L.L
C03CA01	FUROLIX	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	1,612,611 L.L
C03CA01	FUROSEMIDE SALF	G	Furosemide - 20mg/2ml	20mg/2ml	Injectable solution	216,359 L.L
C03CA01	FUROSEMIDE RENAUDIN	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	1,791,342 L.L
C03CA01	FUROSEMIDE S.A.L.F.	G	Furosemide - 250mg/25ml	250mg/25ml	Injectable solution	919,188 L.L
C03CA01	FURESIX 40	G	Furosemide - 40mg	40mg	Tablet	166,381 L.L
C03CA01	FUROSETIC	G	Furosemide - 40mg	40mg	Tablet, scored	121,586 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	491,846 L.L
D06AX01	FUCIDIN OINTMENT	B	Fusidic acid (sodium salt) - 2%	2%	Ointment	345,368 L.L
D06AX01	FUCIKALT	G	Fusidic acid (sodium salt) - 2%	2%	Ointment	209,895 L.L